Article

Phakic lenses continue to capture interest for refractive correction

From the late 1990s to the first decade of the 21st century, there has been increasing interest in different kinds of refractive procedures, Jos? Guell, MD, PhD. One option that has been receiving more and more attention is phakic IOLs. He highlighted some of the factors for this during Cornea Day 2006 at the American Society of Cataract and Refractive Surgery meeting.

From the late 1990s to the first decade of the 21st century, there has been increasing interest in different kinds of refractive procedures, said José Guell, MD, PhD. One option that has been receiving more and more attention is phakic IOLs. He highlighted some of the factors for this during Cornea Day 2006 at the American Society of Cataract and Refractive Surgery meeting.

Regarding refractive results, he said phakic IOLs provide better results than LASIK, especially for patients with high myopia; in addition there is no difference in surgical complication rates between the two types of procedures.

The results with phakic IOLs are stable, adjustable, and reversible and do not differ significantly from LASIK.

However, patient perception of LASIK is better than that of phakic IOLs, said Dr. Guell. He is associate professor of ophthalmology, Aulonoma University of Barcelona, director of the Cornea and Refractive Surgery Unit, Instituto de Microcirugia Ocular de Barcelona, Barcelona.

Another consideration is that the quality of vision is high with phakic IOLs; the patients' vision decreases at a certain point with LASIK.

"Phakic IOLs can provide the safest and most precise refractive correction and can preserve and improve the quality of vision. Corneal ablation should be used to treat lower corrections to preserve the maximum asphericity. We will see with higher corrections an exponential increase in additional surgical techniques because they are reversible. Wavefront modifications in the IOLs will be able to be performed in the near future. We do not yet have enough long-term data from some of the phakic IOLs that are currently available," Dr. Guell concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.